Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.
Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.
Improved versions of our new digital platform for heart failure disease management in China have been developed since April, 2020 rollout.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
Learn More
